Color-Doppler  ||| S:0 E:14 ||| JJ
imaging  ||| S:14 E:22 ||| NN
and  ||| S:22 E:26 ||| CC
arteriovenous  ||| S:26 E:40 ||| JJ
fistula ||| S:40 E:47 ||| NN
:  ||| S:47 E:49 ||| :
preoperative  ||| S:49 E:62 ||| JJ
evaluation  ||| S:62 E:73 ||| NN
and  ||| S:73 E:77 ||| CC
surveillance  ||| S:77 E:90 ||| VBG
The  ||| S:90 E:94 ||| DT
native  ||| S:94 E:101 ||| JJ
arteriovenous  ||| S:101 E:115 ||| JJ
fistula  ||| S:115 E:123 ||| NNS
( ||| S:123 E:124 ||| -LRB-
AVF ||| S:124 E:127 ||| NNP
)  ||| S:127 E:129 ||| -RRB-
is  ||| S:129 E:132 ||| VBZ
the  ||| S:132 E:136 ||| DT
preferred  ||| S:136 E:146 ||| JJ
vascular  ||| S:146 E:155 ||| JJ
access  ||| S:155 E:162 ||| NN
for  ||| S:162 E:166 ||| IN
hemodialysis  ||| S:166 E:179 ||| NN
because  ||| S:179 E:187 ||| IN
of  ||| S:187 E:190 ||| IN
the  ||| S:190 E:194 ||| DT
lower  ||| S:194 E:200 ||| JJR
incidence  ||| S:200 E:210 ||| NN
of  ||| S:210 E:213 ||| IN
complications  ||| S:213 E:227 ||| NNS
and  ||| S:227 E:231 ||| CC
longer  ||| S:231 E:238 ||| JJR
survival  ||| S:238 E:247 ||| NN
in  ||| S:247 E:250 ||| IN
comparison  ||| S:250 E:261 ||| NN
to  ||| S:261 E:264 ||| TO
grafts  ||| S:264 E:271 ||| VB
and  ||| S:271 E:275 ||| CC
central  ||| S:275 E:283 ||| JJ
venous  ||| S:283 E:290 ||| JJ
catheters ||| S:290 E:299 ||| NNS
.  ||| S:299 E:301 ||| .
The  ||| S:301 E:305 ||| DT
use  ||| S:305 E:309 ||| NN
of  ||| S:309 E:312 ||| IN
color-Doppler  ||| S:312 E:326 ||| JJ
sonography  ||| S:326 E:337 ||| NN
in  ||| S:337 E:340 ||| IN
the  ||| S:340 E:344 ||| DT
surgery  ||| S:344 E:352 ||| NN
of  ||| S:352 E:355 ||| IN
vascular  ||| S:355 E:364 ||| JJ
accesses  ||| S:364 E:373 ||| NN
has  ||| S:373 E:377 ||| VBZ
increased  ||| S:377 E:387 ||| VBN
the  ||| S:387 E:391 ||| DT
number  ||| S:391 E:398 ||| NN
of  ||| S:398 E:401 ||| IN
patients  ||| S:401 E:410 ||| NNS
that  ||| S:410 E:415 ||| WDT
are  ||| S:415 E:419 ||| VBP
eligible  ||| S:419 E:428 ||| JJ
for  ||| S:428 E:432 ||| IN
AVF  ||| S:432 E:436 ||| NNP
as  ||| S:436 E:439 ||| IN
it  ||| S:439 E:442 ||| PRP
allows  ||| S:442 E:449 ||| VBZ
to  ||| S:449 E:452 ||| TO
optimize  ||| S:452 E:461 ||| VB
the  ||| S:461 E:465 ||| DT
search  ||| S:465 E:472 ||| NN
for  ||| S:472 E:476 ||| IN
vessels  ||| S:476 E:484 ||| NNS
suitable  ||| S:484 E:493 ||| JJ
for  ||| S:493 E:497 ||| IN
surgical  ||| S:497 E:506 ||| JJ
intervention  ||| S:506 E:519 ||| NN
( ||| S:519 E:520 ||| -LRB-
preoperative  ||| S:520 E:533 ||| FW
vascular  ||| S:533 E:542 ||| FW
mapping ||| S:542 E:549 ||| FW
) ||| S:549 E:550 ||| -RRB-
.  ||| S:550 E:552 ||| .
Furthermore ||| S:552 E:563 ||| RB
,  ||| S:563 E:565 ||| ,
color-Doppler  ||| S:565 E:579 ||| JJ
imaging  ||| S:579 E:587 ||| NN
( ||| S:587 E:588 ||| -LRB-
CDI ||| S:588 E:591 ||| NNP
)  ||| S:591 E:593 ||| -RRB-
has  ||| S:593 E:597 ||| VBZ
improved  ||| S:597 E:606 ||| VBN
the  ||| S:606 E:610 ||| DT
survival  ||| S:610 E:619 ||| NN
of  ||| S:619 E:622 ||| IN
native  ||| S:622 E:629 ||| JJ
AVF  ||| S:629 E:633 ||| NN
by  ||| S:633 E:636 ||| IN
increasing  ||| S:636 E:647 ||| VBG
the  ||| S:647 E:651 ||| DT
early  ||| S:651 E:657 ||| JJ
diagnosis  ||| S:657 E:667 ||| NN
of  ||| S:667 E:670 ||| IN
complications  ||| S:670 E:684 ||| NNS
( ||| S:684 E:685 ||| -LRB-
postoperative  ||| S:685 E:699 ||| JJ
surveillance ||| S:699 E:711 ||| NN
) ||| S:711 E:712 ||| -RRB-
.  ||| S:712 E:714 ||| .
CDI  ||| S:714 E:718 ||| NNP
is  ||| S:718 E:721 ||| VBZ
the  ||| S:721 E:725 ||| DT
only  ||| S:725 E:730 ||| JJ
imaging  ||| S:730 E:738 ||| NN
technique  ||| S:738 E:748 ||| NN
able  ||| S:748 E:753 ||| JJ
to  ||| S:753 E:756 ||| TO
provide  ||| S:756 E:764 ||| VB
both  ||| S:764 E:769 ||| DT
morphological  ||| S:769 E:783 ||| NN
and  ||| S:783 E:787 ||| CC
functional  ||| S:787 E:798 ||| JJ
information  ||| S:798 E:810 ||| NN
about  ||| S:810 E:816 ||| IN
native  ||| S:816 E:823 ||| JJ
vascular  ||| S:823 E:832 ||| JJ
access  ||| S:832 E:839 ||| NN
and  ||| S:839 E:843 ||| CC
it  ||| S:843 E:846 ||| PRP
is  ||| S:846 E:849 ||| VBZ
the  ||| S:849 E:853 ||| DT
only  ||| S:853 E:858 ||| JJ
tool  ||| S:858 E:863 ||| NN
directly  ||| S:863 E:872 ||| RB
available  ||| S:872 E:882 ||| JJ
to  ||| S:882 E:885 ||| TO
the  ||| S:885 E:889 ||| DT
nephrologist ||| S:889 E:901 ||| NN
.  ||| S:901 E:903 ||| .
This  ||| S:903 E:908 ||| DT
aspect  ||| S:908 E:915 ||| NN
is  ||| S:915 E:918 ||| VBZ
undoubtedly  ||| S:918 E:930 ||| RB
an  ||| S:930 E:933 ||| DT
additional  ||| S:933 E:944 ||| JJ
value ||| S:944 E:949 ||| NN
.  ||| S:949 E:951 ||| .
Here  ||| S:951 E:956 ||| RB
we  ||| S:956 E:959 ||| PRP
present  ||| S:959 E:967 ||| VBP
a  ||| S:967 E:969 ||| DT
survey  ||| S:969 E:976 ||| NN
of  ||| S:976 E:979 ||| IN
the  ||| S:979 E:983 ||| DT
applications  ||| S:983 E:996 ||| NNS
of  ||| S:996 E:999 ||| IN
CDI  ||| S:999 E:1003 ||| NNP
in  ||| S:1003 E:1006 ||| IN
the  ||| S:1006 E:1010 ||| DT
surgery  ||| S:1010 E:1018 ||| NN
and  ||| S:1018 E:1022 ||| CC
followup  ||| S:1022 E:1031 ||| NN
of  ||| S:1031 E:1034 ||| IN
AVF ||| S:1034 E:1037 ||| NNP
,  ||| S:1037 E:1039 ||| ,
with  ||| S:1039 E:1044 ||| IN
particular  ||| S:1044 E:1055 ||| JJ
reference  ||| S:1055 E:1065 ||| NN
to  ||| S:1065 E:1068 ||| TO
preoperative  ||| S:1068 E:1081 ||| VB
mapping ||| S:1081 E:1088 ||| NN
,  ||| S:1088 E:1090 ||| ,
AVF  ||| S:1090 E:1094 ||| NNP
maturation  ||| S:1094 E:1105 ||| NN
and  ||| S:1105 E:1109 ||| CC
surveillance ||| S:1109 E:1121 ||| NN
.  ||| S:1121 E:1123 ||| .
